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Abstract
Background: Identifying associations between genotypes and gene expression levels using microarrays has
enabled systematic interrogation of regulatory variation underlying complex phenotypes. This approach has vast
potential for functional characterization of disease states, but its prohibitive cost, given hundreds to thousands of
individual samples from populations have to be genotyped and expression profiled, has limited its widespread
application.
Results: Here we demonstrate that genomic regions with allele-specific expression (ASE) detected by sequencing
cDNA are highly enriched for cis-acting expression quantitative trait loci (cis-eQTL) identified by profiling of 500
animals in parallel, with up to 90% agreement on the allele that is preferentially expressed. We also observed
widespread noncoding and antisense ASE and identified several allele-specific alternative splicing variants.
Conclusion: Monitoring ASE by sequencing cDNA from as little as one sample is a practical alternative to
expression genetics for mapping cis-acting variation that regulates RNA transcription and processing.
Background
The genetics of genome-wide gene expression has
emerged as an important new field with potential to
transform our understanding of a broad scope of topics,
ranging from basic regulation of transcription to
mechanisms of complex human diseases. In most stu-
dies of gene expression genetics, genetically diverse indi-
viduals are genotyped at genetic markers that
characterize most of the common DNA variation in the
population and are also phenotyped by measuring the
abundances of thousands of mRNA transcripts [1].
These molecular phenotypes are then genetically
mapped like any other quantitative trait, revealing quan-
titative trait loci (QTL) where a polymorphism affects a
transcript’s abundance levels [1]. These studies have led
to the construction of regulatory networks that are pre-
dictive of disease states such as obesity in both mouse
and human [2,3]. They have also shown that gene
expression QTL (eQTL) in humans can uncover the
mechanisms of action of disease-associated SNPs pre-
viously implicated by genome-wide association studies
(GWAS) [4,5], and have even implicated new SNPs as
additional disease-associated loci [4]. At the heart of all
eQTL studies is polymorphic gene expression. This can
be caused by genetic variants that act in cis or in trans.
A major difference between the two classes is that
because a cis-acting allele acts only on the chromosomal
copy on which it resides, a heterozygous cis-acting poly-
morphism results in allele-specific effects, such as higher
expression of allele A vs allele B, even though both
alleles are present in the same nucleus and thus experi-
ence the same trans-acting environment [6]. In contrast,
a heterozygous trans-acting polymorphism cannot lead
to allele-specific effects, because it does not differentiate
between the two alleles.
Most studies of gene expression genetics have classi-
fied expression variation within species as due to either
cis-o rtrans-acting factors; this is typically done by
genetically mapping variation in expression levels, and
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to the gene itself is most likely influenced by one or
more cis-acting variants [1,6]. Cis-acting polymorphisms
have been found to be extremely common in all studies
published to date, and generally exert much stronger
e f f e c t so ng e n ee x p r e s s i o nt h a nd otrans-acting poly-
morphisms. For example, recent studies of human gene
expression genetics have inferred between 85-100% of
significant eQTLs to be cis-acting [2,5], although our
power to detect these two types of events has not been
exhaustively compared. trans-acting eQTL may even-
tually be found to be more prevalent, once larger sample
sizes and thus greater power are achieved, and they have
also been found to be useful in the context of coexpres-
sion networks and causal inference [2,3,5].
It has been appreciated for many years–since well
before the first studies of genome-wide gene expression
genetics–that measuring ASE can reveal the presence of
heterozygous cis-acting polymorphisms. In fact, ASE is a
necessary consequence of heterozygous cis-acting poly-
morphisms. ASE can be measured by quantifying the
abundance of each allele of a transcribed heterozygous
polymorphism (such as a SNP) among a gene’st r a n -
scripts. Since the genomic ratio of heterozygous alleles
in a diploid is 1:1, any significant deviation from this
among mRNA transcripts suggests allele-specificity. Pri-
marily due to technical limitations, measuring ASE has
not been widely applied to identify cis-acting poly-
morphisms. The emergence of high-throughput cDNA
sequencing (i.e. RNA/NSR-seq) has enabled whole-
genome identification of ASE and has been applied to
mapping imprinted loci [7,8]. In addition, two targeted
approaches employing PCR [9] and padlock-capture
[10,11] have shown that up to 25% of genes may be pre-
ferentially expressed from one allele and that a signifi-
cant proportion of these are tissue-specific [11].
Although it is assumed that identifying ASE by high-
throughput sequencing is an alternative to mapping
cis-eQTL by microarrays, this has not been shown
experimentally. cis-eQTL result in higher expression of
one allele over the other in any given sample. This bias
consistently favors one parental allele if the causal poly-
morphism is in linkage disequilibrium (LD) with the
transcribed SNPs used to quantify ASE. In this study,
we validate cDNA sequencing toward identifying regions
affected by inheritable cis-acting regulatory variants by
demonstrating extensive overlap between ASE and
cis-eQTL.
Results
Mapping cis-eQTL
Using a custom Agilent murine microarray [12], we pro-
filed 500 adipose and islet samples from an F2 intercross
population constructed from the BTBR and C57BL/6J
strains on an Ob null background (referred to here as
the BTBRxB6 cross), and detected cis-eQTL for expres-
sion traits using a standard regression procedure
[12,13]. We excluded 1,291 genes from this analysis in
which probes overlapped a known [14] or predicted (see
Methods) BTBR/B6 SNP from our analysis, since these
can lead to false-positive cis-eQTL by impacting hybridi-
zation kinetics. At LOD > 3 (FDR = 0.01) we detected
3,367 and 3,819 cis-eQTL genes (of 34,257 on array) in
adipose and islets respectively which we used as baseline
lists for comparison.
Mapping ASE
We performed NSR-seq [15] on 100 pooled adipose and
100 pooled islet samples randomly chosen from the F2
samples (above). We also performed NSR-seq on 100
pooled liver and 100 pooled hypothalamus samples to
assess degree of ASE conservation across tissues (but
did not profile these on arrays). As described previously
[7-11], we identified ASE by taking advantage of sequen-
cing reads that overlap SNPs, using the base identity to
discriminate allelic origin. More than 1,500 genes were
represented by at least 10 allele-specific sequencing
reads (i.e. overlap a BTBR/B6 SNP) in islets and adipose
(Additional File 1, Figure S1), which we empirically
found to be a practical minimum for identifying ASE.
We assessed the probability of ASE using the cumulative
binomial distribution since it models the expected num-
ber of counts of two types, each with a certain probabil-
ity of occurrence. For example, flips of a fair coin follow
the binomial distribution, with probability of 0.5 for
heads or tails in each flip. Similarly, allele-specific read
counts can be regarded as independent trials, where
each allele has some probability of being observed (0.5
for autosomal alleles in F1 s, genotype frequency of pool
in F2s). In order to assess the accuracy of using the
binomial expectation to estimate the significance of
deviation from random, we analyzed allelic expression of
biological replicates from a previous study in which we
studied ASE by NSR-seq in mouse embryos [7]. We
found no significant difference in the extent of agree-
ment between allele-specificr e a dc o u n t so ft w oi n d e -
pendently generated NSR-seq libraries compared to
randomly generated counts from the binomial distribu-
tion (Figure 1a), indicating that our data can be accu-
rately modeled by this distribution. We also observed
good agreement in allelic ratios between these two bio-
logical replicates (Figure 1b). Finally, in agreement with
Emilsson et al. [3] and Zhang et al. [11], in pairwise
comparisons of ASE across four tissues we observed
general agreement in direction of bias toward the same
strain, suggesting that cis-acting effects tend to be con-
served across tissues/cell-types (Figure 1c; Additional
File 1, Figure S2).
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Page 2 of 11Under the null-hypothesis (no allelic bias), the ratio of
BTBR to B6 reads reflects the allelic proportions within
the RNA pool. Although the average allelic ratio was
50:50, we used the microarray genotyping information
to augment the precision of our analysis by exactly
defining the ratio at each locus (see Methods). 2,230
adipose and 1,444 islets genes met our criteria for reli-
ably measuring ASE, most notably containing a mini-
mum of 10 allele-specific sequencing reads covering at
least three SNPs (see Methods). 719 and 501 genes
respectively were also detected in cis-eQTL which by
itself represents a significant overlap (Fisher Exact Test
p < 1e-11).
ASE identified by NSR-seq agrees with cis-eQTL identified
by microarrays
We observed a significant overlaps between cis-eQTL
genes and ASE genes, and the overlap improved with
increasing confidence thresholds of each method (Figure
2). We used genetic additive effect to quantify cis-eQTL
since it captures the magnitude of the difference in tran-
scriptional abundance across the three possible geno-
types at each marker, and all cis-acting eQTL are
expected to show additive behavior. In adipose, the ratio
of observed to expected (see Methods) gene overlap
exceeds 10 at high thresholds (Figure 2a). Since the
overlap is in part dependent on expression (eQTL and
ASE are easier to detect for highly expressed genes), we
also assessed agreement on the direction of bias (B6 vs
BTBR; Figure 2b). Again, agreement improved with
increasing thresholds, frequently exceeding 80% (e.g. at
LBP > 2, add. eff. > 0.05, 115 genes were detected by
both technologies, of which 92 agreed on direction of
bias). We observed similar trends in islets with margin-
ally lower levels of enrichment (Additional File 1, Figure
S3), possibly due to increased variance resulting from
fewer expressed genes and fewer genes exhibiting ASE
(Additional File 1, Figure S1).
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Figure 1 Reproducibility and tissue specificity of ASE measured with NSR-seq. (a) Observed and expected error in biological replicates.
RNA was isolated from independent samples, and subjected to NSR-seq (see methods). The error was calculated as the difference in log2(allelic
ratio) between the two replicates, and is shown in relation to the average number of reads for the SNP in the two replicates (left panel). As
expected, SNPs with more reads show lower error. The theoretically expected errors from the binomial distribution (right panel). Simulated data
was not significantly different than the real data, when comparing errors by the Wilcoxon test (p > 0.2). (b) Ratio of allele-specific sequencing
reads between two biological replicates for RefSeq genes with at least 100 reads. R
2 = 0.84 (n = 289, p = 2.4e-115) (c) ASE conservation of
RefSeq genes between islets and adipose. log(binomial-p) reflects confidence of ASE, and was arbitrarily set to negative when bias was toward
B6 allele. R
2 = 0.20 (n = 887, p = 2.4e-115)
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Page 3 of 11Previous sequencing-based ASE studies used F1 s [7,8]
where both copies of each allele are always present at
exactly equal ratios, thus enabling a simple statistical
analysis of ASE. Our primary goal was validation of the
method. Using the same samples for identifying both
ASE and cis-eQTL was thus essential for avoiding inter-
sample biases and additional effects induced by the
exceptionally high heterozygosity of F1 s. Nonetheless,
we observed strong overlaps in F1 s as well (Additional
File 1, Figure S4), demonstrating that using single sam-
ples is sufficient to map regions affected by cis-acting
variation and that artificial F1 effects are not extensive.
A number of explanations may account for any dis-
agreement on the direction of bias between the NSR-seq
and microarray data. Most obvious are the technical dif-
ferences in determining transcriptional abundance:
microarrays monitor 3′UTR abundance whereas NSR-
seq captures the entire transcript. Any transcriptional
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Figure 2 Genes mapped to cis-eQTL (Array) and genes under allele-specific expression (ASE; NSR-seq) overlap and agree on direction
of allelic bias in adipose. (a) Ratio of observed to expected level of overlapping genes exceeding Genetic Additive Effect and ASE confidence
scores. Histograms along the axes depict the number of genes exceeding Additive Effect or binomial-p thresholds. (b) Proportion of overlapping
genes for which ASE and Additive Effect agree on direction of allelic bias (i.e. higher expression detected from B6 or BTBR allele by both
approaches).
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Page 4 of 11processing effect not reflected in the 3′UTR may thus
lead to an overall difference, and any 3′UTR processing
effect will be exaggerated on arrays. Furthermore, SNPs
in microarray probe regions may lead to artifactual dif-
ferences in BTBR and B6 transcript level measurements,
and false-positive SNP predictions that artifactually bias
sequencing allele counts toward B6 (the reference gen-
ome). To gain insight into these discrepancies, we San-
ger-resequenced SNPs in all genes that disagreed in
their direction of bias between the two technologies at
high ASE and cis-eQTL thresholds in adipose (n = 25
adipose samples, |log(binomial-p)| > 3, |add. eff.| >
0.05). Strain bias in 7 genes could not be sufficiently dis-
tinguished by analyzing trace files. Of the remaining 18
genes, 15 (83%) agreed in direction with NSR-seq, of
which 5 (28%) had no detectable BTBR signal, presum-
ably due to a false-positive SNP, and 3 (17%) agreed
with microarray-inferred strain bias (Additional File 1,
T a b l eS 1 ) .T h i ss u g g e s t st h a tm e a s u r i n gA S Eb yh i g h -
throughput sequencing may be less susceptible to arti-
facts than mapping cis-eQTLs in an F2 population.
ASE is widespread and encompasses noncoding RNA
Since NSR-seq captures all transcripts regardless of
polyadenylation state [15], we were able to assess ASE
across both coding and noncoding regions. In agreement
with previous reports [9-11,16,17] we identified exten-
sive ASE among coding genes (Figure 3a; adipose
shown, see Additional File 1, Figure S5 for islets). We
also observed higher than expected levels of ASE in
noncoding genes (Figure 3b; genes include tRNA,
snRNA, snoRNA, miRNA precursors and other smaller
classes of RNA compiled from fRNAdb [18]). In these
plots, points falling near zero on the Y-axis indicate a
lack of allele-specificity. Using binomial statistics as
described above, we also plotted the 99% confidence
intervals as a function of the total number of informa-
tive reads per transcript (Figure 3, green lines). Many
genes fall outside of the 99% binomial confidence limits
(much greater than 1%), indicating that allele-specific
expression is widespread in these mice.
Comparing the complete observed and expected distri-
butions of allele-specificity (see Methods), we found that
36.7% of the BTBR SNPs covered by at least 10 reads in
adipose showed greater allele-specificity than expected,
and at 100× coverage, this increased to 59.9%. In the
islet data, allelic bias was even more common: 42.0% of
SNPs were biased at 10× coverage, and 68.0% were
biased at 100×. At 100× coverage, we can detect 1.70-
fold differences at p = 0.01 with 50% power (or at p =
0.05 with 82% power); at 1000× coverage, this drops to
1.18-fold at p = 0.01 with 50% power (or 78% power at
p = 0.05). Unfortunately we cannot estimate the total
extent of ASE, since this strongly depends on the
distribution of effect sizes for cis-eQTL (e.g., having
many weak effect sizes below our current detection
threshold would indicate there is still much more ASE
to be found). Future studies with higher coverage of the
transcriptome will be able to address this issue.
Antisense transcription occurs more frequently from the
same allele vs. independent alleles
Widespread antisense transcription in mammals is well
documented [19-21], although a general function for
these transcripts has not been established. Recently, sev-
eral groups have identified clustering of short antisense
transcripts immediately upstream of transcription start
sites (TSSs) [22,23]. In yeast, these short transcripts are
immediate targets of the exosome suggesting that they
are non-functional derivatives of an intrinsically bidirec-
tional RNA polymerase II [24]. The strand-specific nat-
ure of our RNA amplification protocol allowed us to
further explore this by further dissecting antisense tran-
scription by their allelic origin. In order to maximize the
number of assayable sites with antisense transcription,
we used previously published data from F1 B6xCAST/Ei
embryos [7], which have on average >4-fold higher SNP
d e n s i t yo v e rB 6 / B T B R[ 1 4 ] .W eh a v ea l s od o n et h e s e
analyses with BTBRxB6 data and achieved similar, but
as expected, weaker trends resulting from lower sensitiv-
ity (BTBRxB6 analyses shown in Additional File 1, Fig-
ure S6).
Allele-specific antisense transcription occurs in two
forms: antidirectional, where transcription is restricted
to separate alleles and occurs in only one direction from
each allele (Figure 4a), and allele-specific antisense,
where both directions are transcribed from one allele,
and little or no transcription occurs on the other (Figure
4a). Since antidirectional transcripts require independent
cis-acting regulation, predominance of these events over
allele-specific antisense transcripts would suggest that
antisense transcription in general is a functionally regu-
lated process. Although we observed both types of
events, 65/106 of SNPs with bidirectional transcription
(|LBP| > 0) were biased toward expression from the
same allele, versus separate alleles (p = 0.0125, Figure
4b). Of seven SNPs with the strongest antidirectional
transcription (red diamonds in Figure 4b), four are
within introns of Phactr4, one is intronic to Ptprd,a n d
the final two are located in overlapping antisense UTRs
(Trp53bp1/AK050250, and Invs/BC006867). We vali-
dated allelically biased bidirectional transcription in all
four of these regions by Sanger-sequencing (Figure 4c;
and see Additional File 1, Figure S7). Although our
power to make conclusive claims is low, we observed a
significant correlation between the strand of transcrip-
tion and allelic bias (i.e. allelically-biased antisense tran-
scription tends to occur from the same allele). This is in
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Page 5 of 11agreement with the idea that antisense transcription is
in general not an independently regulated process but
rather a consequence of coding-gene expression.
Identification of allele-specific splicing events
Pre-mRNA splicing is a highly regulated process that
involves interplay among dozens of regulatory factors and
RNA sequence motifs. The importance of this process is
epitomized by estimates attributing 15-50% of human
genetic diseases on mutations in splice-site regulatory
sequences [25]. Although these cis-acting effects are widely
thought to exist, they are difficult to detect systematically
[4,26]. By counting sequencing reads that map over splice
junctions and a SNP, NSR/RNA-seq is uniquely suited to
detect these events. This approach is theoretically possible
for any reads that are spliced and overlap a SNP, but is
complicated by differences arising from allele-specific
transcription. We controlled for this effect by focusing on
SNPs that overlap alternatively spliced reads, searching for
cases where the skipped isoform has an allelically shifted
ratio compared to the included isoform (Additional File 1,
Figure S8). We report 10 candidate examples (Table 1). In
most cases the skipped isoform is predicted to disrupt a
conserved protein domain, suggesting that even minor
allele-specific splicing changes may have dramatic func-
tional effects.
Discussion
We found a highly significant overlap in cis-eQTL
genes identified by microarray profiling and ASE genes
identified by NSR-seq. Improving overlap with increas-
ing additive QTL effect sizes and/or LBP demonstrates
that, as expected, both approaches reliably detect
allele-specific expressi o nd e s p i t ean u m b e ro fk e y
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Figure 3 Visualization of allelic bias in NSR-seq data. (a) For each RefSeq transcript in adipose, the total number of informative reads was
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Page 6 of 11differences in the technologies. For example, the
majority of microarray gene-expression platforms,
including the platform used here, rely on 3′-biased
amplification protocols and thus position microarray
probes near the 3′-end of the gene. With NSR-seq we
monitored the entire transcript, including introns,
which we previously found to improve sensitivity [7]
presumably because most intronic reads correspond to
unprocessed pre-mRNA or degradation products. Any
a l l e l e - s p e c i f i ce v e n t so u t s i d et h em i c r o a r r a yp r o b e
region will thus skew the comparison. Unknown SNPs
can also cause disagreement: 1) they can lead to arti-
factual genetic associations if they are within probe
regions [6], 2) can bias allelic representation in NSR-
seq if located within priming sites, and 3) can lead to a
bias towards aligning NSR-seq reads to the reference
genome (though this last scenario is expected to be
rare, since it requires having both a known and an
unknown SNP in the same read; consistent with this
expectation, visual inspection of Figure 3 reveals little
bias). False-positive SNPs accounted for 28% of
extreme cases where NSR-seq disagreed with microar-
rays. Although this is a substantial overestimate of
total effect since selection of these genes was biased
toward strong disagreement, it highlights the impor-
tance of high-quality SNP maps for both methods.
While our results mostly agree with those from more
traditional approaches using hundreds of microarrays to
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Page 7 of 11measure gene expression among F2 mice, there are sev-
eral distinct advantages of the NSR-seq approach. First,
NSR-seq results are not limited by a fixed set of probes,
and because of this we were able to find allele-specific
instances of splicing and antisense transcription that
were invisible to our microarrays. Second, identification
of cis-eQTL does not depend on arbitrary genomic dis-
tance cutoffs with NSR-seq, in contrast to microarray
studies which will inevitably misclassify some trans-
eQTL as cis,a n dvice versa. Third, the NSR-seq
approach can be applied to any outbred diploid or poly-
ploid species, even those for which microarrays are not
readily available. Finally, NSR-seq can be applied to a
single F1 individual, with a single sequencing run cost-
ing several thousand dollars, as opposed to applying
microarrays to each of hundreds of F2 individuals, sav-
ing a great deal of time and expense (though pooling F2
individuals may more closely agree with cis-eQTL from
microarrays, if genetic interactions in the F2 population
are not captured in the F1). On the other hand, the
greatest disadvantage of NSR-seq is its inability to detect
trans-eQTL. Measuring ASE in the context applied here
where animals were pooled at the RNA level cannot be
used to map the genomic region that contains the causal
effect. Sequencing or microarray profiling many samples
will always be required for mapping QTL. A second dis-
advantage is that in outbred species with short LD
blocks (such as human), the causal cis-eQTL poly-
morphism will often not be in LD with any transcribed
SNPs, and in these cases pooling will not reveal ASE.
Third, pooling RNA from different individuals could
i n t r o d u c eb i a s e s .T h e s ec a nb em i n i m i z e db yk e e p i n g
track of the mass of RNA from each individual or by
pooling by equal mass. It is also possible that one or a
few individuals in the pool have significantly different
expression levels and contribute unbiasly to the ASE sig-
nal. We show that this is very unlikely given our strong
agreement on ASE in F1 biological replicates (Figure
1 a ) ,b u tr u l i n gi to u tf o rt h ee n t i r ep o o lw o u l dr e q u i r e
testing individuals. Nevertheless, pooling human samples
has already been shown to reveal many cis-eQTL [17].
To detect cis-eQTL where the causal polymorphism is
not in LD with any transcribed SNPs, NSR-seq can be
performed on individual samples, as long as genotype
phasing is known [17]. A method able to quickly and
efficiently identify cis-eQTL genome-wide will find
applications in many areas. The dependence of cis-eQTL
on environmental conditions–a subject not previously
studied, in large part due to its prohibitive cost–can
now be studied efficiently and comprehensively. The
method can be applied to hybrids between distinct spe-
cies (as has already been done with low-throughput pyr-
osequencing for Drosophila hybrids) to reveal all
cis-acting gene expression differences, and inform us of
the importance of cis-regulation in evolution. Since the
action of positive selection can now be inferred solely
from cis-eQTL (H. Fraser; personal communication),
selection on gene expression can be measured by NSR/
RNA-seq in a wide range of species. And finally, cis-act-
ing polymorphisms have been shown to be highly
enriched for SNPs associated with human disease risk in
genome-wide association studies, so compiling catalogs
of genes affected by cis-eQTL in various tissues, popula-
tions, and disease states could be extremely useful for
inferring which disease associations are likely due to
cis-acting effects on gene expression, and even more
importantly, which genes are perturbed by the disease-
associated variants (see Additional File 1, Supplement).
Table 1 Allele-specific splicing candidates
Gene Exon Included
Reads (B6:CAST)
Exon Skipped
Reads (B6:CAST)
p(ASE) is
less than*
Gene function (Gene
Ontology)
Conserved protein domain encoded by
skipped exon (Pfam)
Slc8a1 6 (2:4) 429 (232:197) 0.344 reduction of cytosolic calcium
ion concentration
No domain reported
Baz2b 30 (9:21) 99 (58:41) 0.021 chromatin modification Bromodomain adj. to zinc finger domain
(PTHR22880)
Eif4enif1 24 (3:21) 18 (12:6) 0.119 protein transport No domain reported
Epb4.1l2 7 (5:2) 6 (2:4) 0.344 cortical actin cytoskeleton
organization
4.1 C-terminal domain (PF05902)
Papd4 6 (6:0) 3 (0:3) 0.125 polynucleotide
adenylyltransferase activity
PAP/OAS1 substrate-binding domain
(SSF81631))
Aqr 8 (8:0) 3 (0:3) 0.125 RNA splicing; body
morphogenesis
DNA2/NAM7 helicase family member
(PTHR10887:SF5)
Ankrd12 32 (9:23) 3 (3:0) 0.125 unknown Ankyrin repeat (SSF48403)
Nudc 27 (11:16) 75 (75:0) 0.221 nuclear migration; nervous
system development
CS (PS51203), HSP20-like chaperones
(SSF49764)
Rbm17 32 (16:16) 5 (5:0) 0.031 mRNA processing, RNA binding Splicing factor 45 (PTHR13288:SF9)
Cacna1h 1118 (378:740) 5 (5:0) 0.031 Calcium transport Voltage-gated_potassium_channels
(SSF81324)
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Validated against expression genetics, cDNA sequencing
is an effective strategy for identifying allele-specific
expression which can be used to map inheritable cis-act-
ing variation. Application across multiple samples has
potential to yield insight into polygenic phenotypes
including complex disease.
Methods
Sample collection and microarray analysis
The BTBR × B6 F2 mice were constructed by inter-
crossing F1 animals obtained by crossing C57BL/6 (B6)
BTBR mice carrying the leptinob/ob (ob) mutation. The
resulting F2 animals were housed in an environmen-
tally-controlled facility on a 12 hr light/dark cycle (6
AM - 6 PM, respectively). Mice were provided free
access to water at all times and to a standard rodent
chow (Purina #5008) ad libitum, except during a fasting
period (8 AM - noon) in order to obtain plasma at 10
weeks of age, after which they were sacrificed by decapi-
tation. For each animal the right gonadal fat pad (adi-
pose) and pancreas were collected for expression
profiling. The adipose tissues were flash frozen in liquid
nitrogen. Intact pancreatic islets were isolated from the
F2 mice using a collagenase digestion procedure as pre-
viously described [27]. A detailed description of islet iso-
lation, RNA purification, and microarray analyses is
available in Additional File 1 (Supplementary Methods).
All animal handling procedures were approved by Uni-
versity of Wisconsin Animal Care and Use Committee.
NSR-seq
Total RNA from 100 adipose, islet, liver, and hypothala-
mus samples (see above) was pooled and subjected to
strand-specific, whole-cell NSR-seq [15]. Libraries were
sent to Illumina (Hayward, California) for single-end 36
nt sequencing for total depth of 2 G/sample. Novoalign
(Novocraft) was used to align against NCBI mouse gen-
ome release 36 (UCSC Feb. 2006 release [mm8]) and a
collection of splice junctions generated from Refseq
genes [28], ENSEMBL genes [29], and UCSC Known
Genes [30]. Predicted splice junctions from ESTs [30],
Genscan [30], and N-scan predictions [30] were also
considered in regions that lack coding gene models. All
possible splice sites spanning up to two exon skipping
events in gene/transcript models above were repre-
sented. A minimum of 5 nt overlap per flanking junc-
tion sequence was required for alignment to be
considered, selected on basis of maximizing overall
alignment sensitivity (data not shown). All reads that
aligned uniquely to the genome or splice-sites, and
redundantly mapped reads that overlap unique reads in
only one genomic location, were retained for further
analysis. 73,556,741/89,349,136 adipose, 89,418,898/
108,429,611 islets, 81,359,243/98,250,529 hypothalamus,
and 49,297,475/61,390,433 liver were successfully
aligned by employing the above criteria. BTBR/B6 raw
sequence data is available at NCBI Short Read Archive
under accession SRA008619.3; previously published
CAST/B6 data is accessible under SRA008621.10.
Quantification of allele-specific events from sequencing
data
ASE was assessed by summing allele-specific reads that
align over independently identified SNPs [14]; using the
SNP to distinguish the allelic origin. For comparison
with microarray transcript levels, allelic counts were
summed across all SNPs within the transcript bound-
aries (including introns), provided that the sequencing
reads were in the same orientation as the transcript. To
exclude artifactual allelic bias arising from false-positive
SNPs or differential priming events, we required a mini-
mum of three SNPs within the gene and agreement on
strain bias at the majority of all SNPs/transcript. We
excluded SNPs where the average Illumina-phred score
was below 20, since scores below 20 do not accurately
reflect sequencing errors (Illumina, personal communi-
cation). We also excluded C/A, A/C, and G/T (B6/
BTBR) SNPs since the sequence data had dispropor-
tional amounts of reference mismatches of these variety,
indicative of high error rates.
Expected null overlap of genes under cis-eQTL and
genes with ASE with the same directional bias was com-
puted as
Array genes Add Eff
All genes
Seq genes LBP
All genes
__
_
_
_
> ⎛
⎝
⎜
⎞
⎠
⎟
> ⎛
⎝
⎜ ⎜
⎞
⎠
⎟()
⎛
⎝
⎜
⎞
⎠
⎟ All genes _
1
2
where All_genes was the total number of genes on the
microarray after removal of genes with SNPs in probe
regions (n = 34,257).
Antisense analysis was conducted for SNPs where reads
mapped to both strands. Since our NSR-seq approach
may incorrectly detect up to 0.7% antisense reads [15],
we used the binomial to exclude potential artifacts where
expression is predominant from one strand (p < 1e-4;
Bonferroni-corrected). LBP scores were normalized to
the mean for each strand (Figure 4b) to correct for over-
lap arising from slightly higher numbers of B6 reads than
BTBR (presumably from genomic alignment bias). Allele-
specific splicing was assessed when a SNP overlaps reads
that support an alternative splice junction (i.e. both iso-
forms are represented). Only reads with the same orien-
tation as the spliced transcript were considered.
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Page 9 of 11Experimental validation of allele-specific antisense events
0.5 ug total RNA pooled from four B6 × CAST and four
CAST × B6 9.5 day-old embryos was either 1) reverse
transcribed using Qiagen OneStep RT-PCR kit (Qiagen)
according to the manufacturer’si n s t r u c t i o n sw i t h3 5
rounds of PCR (for alternative splice-site amplification),
or 2) reverse-transcribed with superscript III (Invitro-
gen), RNAse H treated (Invitrogen), and amplified by
Roche high-Fidelity PCR (Roche; 35 cycles) according to
the manufacturer’s instructions (for strand-specific
amplification of antisense transcription). Primer
sequences are listed in Additional File 1, Table S2.
Additional material
Additional file 1: Supplemental Material. Supplemental Figures, Tables,
Methods, and Discussion Supplement
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